Varying concentrations of octreotide acetate (Sandostatin®) and diamorphine hydrochloride were prepared and stored in polypropylene syringes at 37°C in the dark. The solutions were analysed for octreotide acetate content using a validated HPLC method at regular intervals over a 48-h period. The results indicate that octreotide acetate remains stable in the presence of diamorphine hydrochloride at 37°C for 24 h. In addition, the solutions prepared maintained their clarity, with no signs of precipitation upon visual examination under normal light conditions.
Khoo D, Riley J, Waxman J. Control of emesis in bowel obstruction in terminally ill patients. Lancet1992; 339: 375–376.
2.
Mercadante S, Maddaloni S. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage1992; 7: 496–498.
3.
Mercadante S, Caraceni A, Simonette M. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med1993; 7: 295–299.
4.
Mercadante S, Kargar J, Nicolosi G. Octreotide may prevent definitive intestinal obstruction. J Pain Symptom Manage1997; 13: 352–355.
5.
Reynolds JEF ed. Martindale: the extra pharmacopoeia, 31st edn.London: The Royal Pharmaceutical Society, 1996: 1289.
6.
Mercadante S. The role of octreotide acetate in palliative care. J Pain Symptom Manage1994; 9: 406–411.
7.
Riley J, Fallon M. Octreotide in terminal malignant obstruction of the gastrointestinal tract. Eur J Palliat Care1994; 1: 23–25.
8.
Ripley RG, Ritchie DJ, Holstad SG. Stability of octreotide acetate in polypropylene syringes at 5 and -20°C. Am J Health Sys Pharm1995; 52: 1910–1911.
9.
Kyaterekera N, Tettey JN, Skellern GG et al. Stability of octreotide in the presence of diamorphine hydrochloride. J Pharm Pharmacol1997; 49: 8.
10.
Kyaterekera N, Tettey JN, Skellern GG et al. HPLC determination of octreotide acetate in compound formulations of Sandostatin® and diamorphine hydrochloride. J Pharm Biomed Anal1999; 21: 327–330.
11.
Omar OA, Hoskin PJ, Johnston A, Hanks GW, Turner P. Diamorphine stability in aqueous solution for subcutaneous infusion. J Pharm Pharmacol1989; 41: 275–277.
